Lacosamide
Lacosamide is an injectable medication used to treat partial-onset seizures in adults with epilepsy. It comes as a 10 mg/mL solution in single-dose vials for intravenous use, available in cartons of 10 vials. This generic version is approved under ANDA214677 by Fresenius Kabi USA. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Lacosamide is an injectable medication used to treat partial-onset seizures in adults with epilepsy. It comes as a 10 mg/mL solution in single-dose vials for intravenous use, available in cartons of 10 vials. This generic version is approved under ANDA214677 by Fresenius Kabi USA. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Lacosamide",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Lacosamide — ANDA 209301 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209301"
}
]
|
| identifier | ANDA209301 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"drug-safety",
"fda",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Lacosamide |
